CTIX's stock price will speak for itself with its positive results in the the Phase 1 trial.  That's all that matters in the case of this company's stock price.   As we all know, the naysayers/shorts/agitators will pop out of the woodwork and litter the message boards with their foul posts, but as long as we know what we own, and are current in our knowlege, and filled with conviction,  and the company keeps delivering, we will be fine.  As of this moment, we are doing quite well!

It would seem that the Psorias drug would potentially be approved first and in a relatively swift fashion so I would characterize CTIX as a dermatology company at the moment while Kevetrin works through the phases.  Of course that could change fast if the data is good and FDA fast tracks Kevetrin to Phase 3.  The beauty of Kevetrin is that it could have so many uses if it's safe and non cytotoxic.  I will drool onto my shoes if we get that kind of PK report.